A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons

Polycyclic aromatic hydrocarbons (PAHs), aryl hydrocarbon receptor (AHR) ligands, induce atherogenesis. Liver X receptor (LXR) α is known to be involved in the control of cholesterol homeostasis. Thus, the purpose of this study was to investigate the effects of 3-methlycholanthrene (MC), one of the...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 335; no. 1; pp. 220 - 226
Main Authors Iwano, Shunsuke, Nukaya, Manabu, Saito, Tetsuya, Asanuma, Fumie, Kamataki, Tetsuya
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 16.09.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Polycyclic aromatic hydrocarbons (PAHs), aryl hydrocarbon receptor (AHR) ligands, induce atherogenesis. Liver X receptor (LXR) α is known to be involved in the control of cholesterol homeostasis. Thus, the purpose of this study was to investigate the effects of 3-methlycholanthrene (MC), one of the PAHs, on LXRα-mediated signal transductions. We found that expression of mRNAs for ATP binding cassette A1, sterol regulatory element binding protein 1c (SREBP-1c), fatty acid synthase, and stearoyl-CoA desaturase was suppressed by treatment of HepG2 cells with MC. A luciferase reporter assay revealed that LXRα- and SREBP-1c-mediated transactivations were inhibited by MC via AHR. Based on these lines of evidence, we propose that down-regulation of the LXRα-regulated genes by PAHs is one of the causes responsible for atherosclerosis induced by PAHs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2005.07.062